486 related articles for article (PubMed ID: 15509629)
21. Regulation of p38 MAP kinase in CD4+ lymphocytes by infliximab therapy in patients with rheumatoid arthritis.
Garfield BE; Krahl T; Appel S; Cooper SM; Rincón M
Clin Immunol; 2005 Aug; 116(2):101-7. PubMed ID: 15914087
[TBL] [Abstract][Full Text] [Related]
22. CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets.
Mohan K; Cordeiro E; Vaci M; McMaster C; Issekutz TB
Eur J Immunol; 2005 Jun; 35(6):1702-11. PubMed ID: 15884054
[TBL] [Abstract][Full Text] [Related]
23. [Clinical experience with TNF-alpha inhibitors in rheumatoid arthritis].
Wallenius M; Rødevand E; Skomsvoll JF
Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1664-6. PubMed ID: 15976836
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis.
Li J; Shen W; Kong K; Liu Z
Scand J Immunol; 2006 Nov; 64(5):515-22. PubMed ID: 17032244
[TBL] [Abstract][Full Text] [Related]
25. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
[TBL] [Abstract][Full Text] [Related]
26. Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab.
Sekiguchi N; Kawauchi S; Furuya T; Inaba N; Matsuda K; Ando S; Ogasawara M; Aburatani H; Kameda H; Amano K; Abe T; Ito S; Takeuchi T
Rheumatology (Oxford); 2008 Jun; 47(6):780-8. PubMed ID: 18388148
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.
Nanki T; Shimaoka T; Hayashida K; Taniguchi K; Yonehara S; Miyasaka N
Arthritis Rheum; 2005 Oct; 52(10):3004-14. PubMed ID: 16200580
[TBL] [Abstract][Full Text] [Related]
28. 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis.
Colin EM; Asmawidjaja PS; van Hamburg JP; Mus AM; van Driel M; Hazes JM; van Leeuwen JP; Lubberts E
Arthritis Rheum; 2010 Jan; 62(1):132-42. PubMed ID: 20039421
[TBL] [Abstract][Full Text] [Related]
29. Effect of treatment of rheumatoid arthritis with infliximab on IFN gamma, IL4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity.
Kawashima M; Miossec P
Ann Rheum Dis; 2005 Mar; 64(3):415-8. PubMed ID: 15286007
[TBL] [Abstract][Full Text] [Related]
30. Asthma severity is associated with an increase in both blood CXCR3+ and CCR4+ T cells.
Kurashima K; Fujimura M; Myou S; Ishiura Y; Onai N; Matsushima K
Respirology; 2006 Mar; 11(2):152-7. PubMed ID: 16548899
[TBL] [Abstract][Full Text] [Related]
31. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F
J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556
[TBL] [Abstract][Full Text] [Related]
32. A novel predictor of clinical response to methotrexate in patients with rheumatoid arthritis: a pilot study of in vitro T cell cytokine suppression.
Haroon N; Srivastava R; Misra R; Aggarwal A
J Rheumatol; 2008 Jun; 35(6):975-8. PubMed ID: 18464312
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
Hamdi H; Mariette X; Godot V; Weldingh K; Hamid AM; Prejean MV; Baron G; Lemann M; Puechal X; Breban M; Berenbaum F; Delchier JC; Flipo RM; Dautzenberg B; Salmon D; Humbert M; Emilie D;
Arthritis Res Ther; 2006; 8(4):R114. PubMed ID: 16859506
[TBL] [Abstract][Full Text] [Related]
34. Cytokine profile of t lymphocytes from peripheral blood and bronchoalveolar lavage fluid in patients with active pulmonary tuberculosis.
Boras Z; Juretić A; Gagro A; Pavelić Lj
Scand J Immunol; 2007 Mar; 65(3):257-64. PubMed ID: 17309780
[TBL] [Abstract][Full Text] [Related]
35. Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis.
Karanikas G; Schuetz M; Wahl K; Paul M; Kontur S; Pietschmann P; Kletter K; Dudczak R; Willheim M
Clin Endocrinol (Oxf); 2005 Aug; 63(2):191-6. PubMed ID: 16060913
[TBL] [Abstract][Full Text] [Related]
36. RF positivity has substantial influence on the peripheral memory B-cell compartment and its modulation by TNF inhibition.
Roll P; Muhammad K; Schumann M; Kleinert S; Tony HP
Scand J Rheumatol; 2012 May; 41(3):180-5. PubMed ID: 22400711
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis.
Gattorno M; Prigione I; Morandi F; Gregorio A; Chiesa S; Ferlito F; Favre A; Uccelli A; Gambini C; Martini A; Pistoia V
Arthritis Res Ther; 2005; 7(2):R256-67. PubMed ID: 15743472
[TBL] [Abstract][Full Text] [Related]
38. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients.
Kao JK; Hsue YT; Lin CY
J Microbiol Immunol Infect; 2007 Oct; 40(5):419-27. PubMed ID: 17932602
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of CXCR6 and CXCR3 in lymphocytes from birch-allergic patients.
Casas R; Lindau C; Zetterström O; Duchén K
Scand J Immunol; 2008 Sep; 68(3):351-61. PubMed ID: 18782262
[TBL] [Abstract][Full Text] [Related]
40. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.
Kapetanovic MC; Saxne T; Nilsson JA; Geborek P
Rheumatology (Oxford); 2007 Apr; 46(4):608-11. PubMed ID: 17114801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
